OptiNose Inc (OPTN.OQ)
OPTN.OQ on NASDAQ Stock Exchange Global Select Market
Change (% chg)
OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The... (more)
No Ratios Available.